SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (240)11/25/1997 1:14:00 AM
From: chirodoc   of 569
 
<<<<<<<Your right - of course. Its illogical. And I was being
illogical

.........i think you were actually very logical when you said that you worried about their marketing campaign--if they do not get a head start now it is possible that anika or another competitor could get the jump on them. that worries me also.

........however, i really don't think that we should worry about nsaid's being competition. however, i am always one to worry so here are my worries: 1. they do not market correctly and this leads to 2. poor acceptance by docs and this leads to 3. higher prices because they cannot turnover enough stock and then 4. voila another competitor.

........however, that is a very pessimistic example. realistically i think with just good marketing (not great) this stock is a lay-up with a 6-12 month appreciation that will beat the market.

.......keep me posted even on your paranoia

i'm paranoid too,

chirodoc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News